Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,497
Closed -$410K 361
2025
Q3
$410K Sell
1,497
-138
-8% -$37.7K 0.03% 203
2025
Q2
$422K Buy
+1,635
New +$390K 0.04% 177
2025
Q1
Sell
-2,855
Closed -$653K 254
2024
Q4
$653K Buy
2,855
+27
+1% +$6.5K 0.05% 155
2024
Q3
$690K Buy
+2,828
New +$632K 0.06% 120
2023
Q3
Sell
-1,474
Closed -$322K 387
2023
Q2
$322K Buy
1,474
+295
+25% +$65.7K 0.02% 288
2023
Q1
$258K Sell
1,179
-829
-41% -$180K 0.02% 348
2022
Q4
$418K Sell
2,008
-42
-2% -$9.23K 0.04% 247
2022
Q3
$430K Sell
2,050
-679
-25% -$155K 0.04% 224
2022
Q2
$572K Sell
2,729
-323
-11% -$68.8K 0.05% 194
2022
Q1
$740K Buy
+3,052
New +$738K 0.05% 181

Other funds holding RMD

American Trust's RMD Position: Q4 2025 in Review

American Trust sold out of ResMed (RMD) in Q4 2025, closing a stake of 1,497 shares — an estimated $410K sold.

American Trust first reported a position in RMD in Q1 2022 and held it in 10 quarters. The position peaked at $740K in Q1 2022. 947 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • American Trust reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • American Trust sold 1,497 ResMed shares in Q4 2025, an estimated $410K.
  • American Trust first reported a position in ResMed in Q1 2022 and held it in 10 quarters.
  • American Trust's ResMed position peaked at $740K in Q1 2022.
  • 947 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on American Trust's 13F filing for Q4 2025, filed 17 Feb 2026.